Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

GERN Company Profile and Key Details

NASDAQ : GERN

Geron

$1.14
0.001+0.09%
Open: 2:00 PM
56.45
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Geron Corporation (GERN) stock surged +0.09%, trading at $1.14 on NASDAQ, up from the previous close of $1.14. The stock opened at $1.13, fluctuating between $1.12 and $1.16 in the recent session.

Stock Snapshot

1.135
Prev. Close
722.9M
Market Cap
1.12
Day Low
-5.4
P/E Ratio
-0.21
EPS (TTM)
-0.28
Cash Flow per Share
1.13
Open
636.92M
Number of Shares
1.16
Day High
94.74%
Free Float in %
0.42
Book Value
3.79M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 29, 20251.171.171.131.1410.27M
Jul 28, 20251.271.281.131.1522.62M
Jul 25, 20251.301.301.251.266.74M
Jul 24, 20251.331.331.271.289.31M
Jul 23, 20251.301.371.281.3310.43M
Jul 22, 20251.201.311.201.288.73M
Jul 21, 20251.261.291.221.238.29M
Jul 18, 20251.321.341.241.245.29M
Jul 17, 20251.271.331.251.295.22M
Jul 16, 20251.281.331.261.278M
Jul 15, 20251.331.341.261.267.38M
Jul 14, 20251.301.351.301.345.31M
Jul 11, 20251.331.381.301.327.53M
Jul 10, 20251.441.441.301.3812.01M
Jul 09, 20251.401.481.391.449.92M
Jul 08, 20251.391.431.361.399.11M
Jul 07, 20251.401.441.371.375.93M
Jul 03, 20251.411.431.381.434.02M
Jul 02, 20251.391.461.341.4010.31M
Jul 01, 20251.391.471.371.3814.46M

Contact Details

Foster City, CA 94404

United States

https://www.geron.com650 473 7700

About Company

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Company Information

Employees229
Beta0.68
Sales or Revenue$237.00K
5Y Sales Change%-0.931%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Geron Corporation (GERN) stock price?
Geron Corporation (NASDAQ: GERN) stock price is $1.14 in the last trading session. During the trading session, GERN stock reached the peak price of $1.16 while $1.12 was the lowest point it dropped to. The percentage change in GERN stock occurred in the recent session was 0.09% while the dollar amount for the price change in GERN stock was $0.00.
GERN's industry and sector of operation?
The NASDAQ listed GERN is part of Biotechnology industry that operates in the broader Healthcare sector. Geron Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of GERN?
Ms. Melissa A. Kelly Behrs
Executive Vice President of Bus. Operations & Chief Alliance Officer
Dr. Andrew J. Grethlein
Executive Vice President & Chief Operating Officer
Mr. Anil Kapur
Executive Vice President of Corporation Strategy & Chief Commercial Officer
Mr. Scott Samuels
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Stephen N. Rosenfield J.D.
Executive Vice President, Chief Legal Officer & Corporation Sec.
Dr. John A. Scarlett M.D.
Chairman, Pres & Chief Executive Officer
Ms. Shannon Odam
Vice President of HR
Mr. Edward E. Koval
Executive Vice President & Chief Bus. Officer
Dr. Faye Feller M.D.
Executive Vice President & Chief Medical Officer
Ms. Olivia Kyusuk Bloom
Executive Vice President of Fin., Chief Financial Officer & Treasurer
How GERN did perform over past 52-week?
GERN's closing price is 0.44% higher than its 52-week low of $1.12 where as its distance from 52-week high of $4.89 is -76.79%.
How many employees does GERN have?
Number of GERN employees currently stands at 229.
Link for GERN official website?
Official Website of GERN is: https://www.geron.com
How do I contact GERN?
GERN could be contacted at phone 650 473 7700 and can also be accessed through its website. GERN operates from 919 East Hillsdale Boulevard, Foster City, CA 94404, United States.
How many shares of GERN are traded daily?
GERN stock volume for the day was 3.79M shares. The average number of GERN shares traded daily for last 3 months was 10.76M.
What is the market cap of GERN currently?
The market value of GERN currently stands at $722.90M with its latest stock price at $1.14 and 636.92M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph